Xi an Manareco New Materials Co., Ltd.
Empowering Pharma Businesses with PDMO Services

Pharmaceutical intermediates are pivotal building blocks in active pharmaceutical ingredient (API) synthesis. These intermediates enable the efficient and controlled transformation of raw materials into safe and effective API by providing a structured and reliable chemical pathway to producing lifesaving drugs and therapies. The quality and consistency of the intermediates and APIs are paramount in ensuring integrity, purity, and therapeutic efficacy.

Xi’an Manareco sets a new standard for excellence in this regard through its robust API and intermediate manufacturing facilities (1500+ reactors), 37 years of expertise and comprehensive partnership development and manufacturing organization (PDMO) services.

“We are a tech-driven enterprise focused on the research, development, production, and sales of specialized organic new materials, with three intermediate plants operating in ISO system and one cGMP plant offering superior capability,” says Mr. Wang Xiaowei, CEO.

Xi’an Manareco can act as a one-stop outsourcing partner for pharmaceutical intermediates, from investigational to large-scale commercial development. The company caters to developing and optimizing innovative process routes, creating and verifying analysis methods, and registration support through all the stages of an investigational new drug (IND) application.

Mr. Wang Xiaowei shares, “The best service is accompanying. We have been accompanying a big pharma company in Japan for many years, responding every single need from it, and we were honored to see a new anti-cancer drug approved by the local authority.”

Xi’an Manareco’s strategic contract development and manufacturing organization (CDMO) services, combined with its team’s insightful experience and careful, thoughtful approaches, help pharma companies tackle every challenge. Following a systematic methodology during client engagements they help identifying new business priorities, navigating the regulatory maze, and staying on top of the trends in a dynamic market.

Typically, customers approach Manareco with the molecular structure of the desired product, often unique and innovative. Leveraging their extensive experience, Xi’an Manareco’s dedicated chemists, technicians, sales personnel, and coordinators collaboratively tackle the project. The process begins with R&D efforts to develop the desired chemical compound at its labs. Once successful, the process is scaled up to pilot lines, where Xian Manareco’s manufacturing capacity supports all kinds of reactions. This effective and efficient approach ensures continuous production, expected yield, and timely delivery for API and intermediate production in larger batches.
Various challenges encountered during the production process have been successfully resolved by the subject matter experts at Xi’an Manareco. The company’s comprehensive human resources efforts ensure the recruitment of highly skilled individuals, including chemists with extensive organic synthesis experience. They are crucial when unexpected problems arise while scaling the process from the lab to pilot lines. With its chemists onsite, Xi’an Manareco promptly resolves issues, working with the research center and project teams to deliver successful outcomes. The company’s commitment to fast and effective problem-solving, combined with a customer-centric approach, has garnered positive feedback from satisfied clients who appreciate the reliability of Xi’an Manareco’s services.

Mr. Wang Xiaowei concentrates, “Long-term and in-depth cooperation is what we pursue, which is why we call ourselves a PDMO (Partnership Development and Manufacturing Organization).”

Although it focuses primarily on PDMO services for pharmaceuticals, Xi’an Manareco also provides expertise in display and electronic materials sectors. While the core principles of organic synthesis apply to these sectors, the key difference lies in the stringent regulatory requirements imposed on API development. Xi’an Manareco’s API plant ensures compliance with these regulations, while the multifunctional reactors in the ISO plants produce intermediates. This integrated approach ensures it maintains its commitment to versatility and efficiency across all manufacturing endeavors.

Xi’an Manareco’s dedication to PDMO services, backed by cutting-edge technologies and a skilled workforce, positions it as a trusted and reliable contract manufacturing partner for pharmaceutical businesses in the APAC region. Its systematic approach and commitment to problem-solving and customer satisfaction solidify its reputation as a leading CDMO in the pharmaceutical industry.